Prenostics
2 known investors
Find your way into Prenostics
Prenostics develops a blood test to detect the earliest stages of cancer (stages 0-2), earlier than current methods, aiming to enable curative treatment. Its initial clinical targets are women at elevated risk of ovarian cancer and people with indeterminate lung nodules.
Founders & leadership
SB
Sarah BlagdenFounder & CSO
Investors · 2
In the news
Frequently asked questions
- What does Prenostics do?
- Prenostics develops a blood test to detect the earliest stages of cancer (stages 0-2), earlier than current methods, aiming to enable curative treatment. Its initial clinical targets are women at elevated risk of ovarian cancer and people with indeterminate lung nodules.
- Who founded Prenostics?
- Prenostics was founded by Sarah Blagden.
- Who are Prenostics's investors?
- Prenostics's investors include Pace Ventures, Sie Ventures.